nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromodiphenhydramine—SLC22A6—Enalapril—coronary artery disease	0.206	0.227	CbGbCtD
Bromodiphenhydramine—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.156	0.172	CbGbCtD
Bromodiphenhydramine—SLC22A6—Captopril—coronary artery disease	0.155	0.17	CbGbCtD
Bromodiphenhydramine—SLC22A6—Pravastatin—coronary artery disease	0.146	0.161	CbGbCtD
Bromodiphenhydramine—SLC22A6—Furosemide—coronary artery disease	0.124	0.137	CbGbCtD
Bromodiphenhydramine—SLC22A6—Losartan—coronary artery disease	0.122	0.134	CbGbCtD
Bromodiphenhydramine—Tamoxifen—SULT1A1—coronary artery disease	0.00126	0.133	CrCbGaD
Bromodiphenhydramine—Doxepin—HRH2—coronary artery disease	0.000831	0.0876	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HRH2—coronary artery disease	0.000643	0.0678	CrCbGaD
Bromodiphenhydramine—Toremifene—ESR1—coronary artery disease	0.000549	0.0579	CrCbGaD
Bromodiphenhydramine—Tolterodine—CYP2C19—coronary artery disease	0.000365	0.0385	CrCbGaD
Bromodiphenhydramine—Tamoxifen—ESR2—coronary artery disease	0.000356	0.0375	CrCbGaD
Bromodiphenhydramine—Fluoxetine—CYP2C19—coronary artery disease	0.000348	0.0367	CrCbGaD
Bromodiphenhydramine—Imipramine—SLC22A3—coronary artery disease	0.000346	0.0365	CrCbGaD
Bromodiphenhydramine—Amitriptyline—OPRD1—coronary artery disease	0.000339	0.0358	CrCbGaD
Bromodiphenhydramine—Carbinoxamine—CYP2C19—coronary artery disease	0.000313	0.033	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—HTR2A—coronary artery disease	0.000309	0.0325	CrCbGaD
Bromodiphenhydramine—Fluoxetine—HTR2A—coronary artery disease	0.000282	0.0298	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CYP2C19—coronary artery disease	0.000271	0.0286	CrCbGaD
Bromodiphenhydramine—Fenoprofen—PTGS2—coronary artery disease	0.000258	0.0272	CrCbGaD
Bromodiphenhydramine—Fenoprofen—ALB—coronary artery disease	0.00023	0.0243	CrCbGaD
Bromodiphenhydramine—Atomoxetine—CYP2C19—coronary artery disease	0.000224	0.0236	CrCbGaD
Bromodiphenhydramine—Imipramine—HTR7—coronary artery disease	0.00022	0.0232	CrCbGaD
Bromodiphenhydramine—Tamoxifen—ESR1—coronary artery disease	0.000219	0.0231	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR7—coronary artery disease	0.000219	0.023	CrCbGaD
Bromodiphenhydramine—Fluoxetine—ALB—coronary artery disease	0.000193	0.0204	CrCbGaD
Bromodiphenhydramine—Atomoxetine—HTR2A—coronary artery disease	0.000181	0.0191	CrCbGaD
Bromodiphenhydramine—Diphenhydramine—CYP2C19—coronary artery disease	0.000181	0.019	CrCbGaD
Bromodiphenhydramine—Tamoxifen—CYP2C19—coronary artery disease	0.000176	0.0185	CrCbGaD
Bromodiphenhydramine—Doxepin—CYP2C19—coronary artery disease	0.000175	0.0185	CrCbGaD
Bromodiphenhydramine—Promazine—CYP2C19—coronary artery disease	0.000156	0.0164	CrCbGaD
Bromodiphenhydramine—Doxepin—HTR2A—coronary artery disease	0.000142	0.015	CrCbGaD
Bromodiphenhydramine—Imipramine—CYP2C19—coronary artery disease	0.000136	0.0144	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CYP2C19—coronary artery disease	0.000136	0.0143	CrCbGaD
Bromodiphenhydramine—Promazine—HTR2A—coronary artery disease	0.000126	0.0133	CrCbGaD
Bromodiphenhydramine—Imipramine—HTR2A—coronary artery disease	0.000111	0.0117	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR2A—coronary artery disease	0.00011	0.0116	CrCbGaD
Bromodiphenhydramine—Amitriptyline—ALB—coronary artery disease	7.52e-05	0.00793	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADM2—coronary artery disease	7.03e-05	0.000869	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCL10—coronary artery disease	6.94e-05	0.000857	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL4—coronary artery disease	6.93e-05	0.000857	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—OPRD1—coronary artery disease	6.93e-05	0.000857	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—coronary artery disease	6.91e-05	0.000854	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—coronary artery disease	6.9e-05	0.000853	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—HMOX1—coronary artery disease	6.84e-05	0.000845	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—UTS2—coronary artery disease	6.81e-05	0.000841	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—ADRB2—coronary artery disease	6.73e-05	0.000832	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TMED2—coronary artery disease	6.66e-05	0.000824	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PLCB3—coronary artery disease	6.59e-05	0.000815	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—P2RY12—coronary artery disease	6.59e-05	0.000815	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	6.56e-05	0.000811	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—APOB—coronary artery disease	6.55e-05	0.00081	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CASR—coronary artery disease	6.53e-05	0.000806	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AVPR1A—coronary artery disease	6.4e-05	0.000791	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—BDKRB1—coronary artery disease	6.4e-05	0.000791	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GNA12—coronary artery disease	6.4e-05	0.000791	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RLN3—coronary artery disease	6.36e-05	0.000786	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LRP8—coronary artery disease	6.36e-05	0.000786	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DGKZ—coronary artery disease	6.36e-05	0.000786	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—coronary artery disease	6.32e-05	0.000781	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADM—coronary artery disease	6.23e-05	0.000769	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—UTS2—coronary artery disease	6.18e-05	0.000764	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AES—coronary artery disease	6.09e-05	0.000753	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EDN2—coronary artery disease	6.09e-05	0.000753	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PDE4B—coronary artery disease	6.07e-05	0.00075	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	6.06e-05	0.000749	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—EDN1—coronary artery disease	6.02e-05	0.000744	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—P2RY12—coronary artery disease	5.99e-05	0.00074	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PLCB3—coronary artery disease	5.99e-05	0.00074	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCL5—coronary artery disease	5.97e-05	0.000738	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CX3CR1—coronary artery disease	5.93e-05	0.000732	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CASR—coronary artery disease	5.93e-05	0.000732	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HRH2—coronary artery disease	5.87e-05	0.000725	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—BDKRB1—coronary artery disease	5.81e-05	0.000718	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GNA12—coronary artery disease	5.81e-05	0.000718	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CX3CL1—coronary artery disease	5.81e-05	0.000718	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PPP3R1—coronary artery disease	5.7e-05	0.000705	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADM—coronary artery disease	5.65e-05	0.000699	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCR3—coronary artery disease	5.55e-05	0.000686	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	5.52e-05	0.000682	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PDE4B—coronary artery disease	5.51e-05	0.000681	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	5.4e-05	0.000668	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RHOC—coronary artery disease	5.33e-05	0.000658	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ACVR1B—coronary artery disease	5.33e-05	0.000658	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR2A—coronary artery disease	5.26e-05	0.000651	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—C3—coronary artery disease	5.26e-05	0.00065	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL2—coronary artery disease	5.22e-05	0.000645	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—APOA1—coronary artery disease	5.18e-05	0.000641	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NEDD4—coronary artery disease	5.18e-05	0.00064	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—F2R—coronary artery disease	5.16e-05	0.000637	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PDE3A—coronary artery disease	5.05e-05	0.000624	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RAMP2—coronary artery disease	5.05e-05	0.000624	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PF4—coronary artery disease	5.05e-05	0.000624	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MDK—coronary artery disease	5.05e-05	0.000624	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR3—coronary artery disease	5.04e-05	0.000623	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—EDNRB—coronary artery disease	5e-05	0.000617	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—AGT—coronary artery disease	4.99e-05	0.000617	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RALBP1—coronary artery disease	4.82e-05	0.000595	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—F2RL1—coronary artery disease	4.82e-05	0.000595	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NPY5R—coronary artery disease	4.82e-05	0.000595	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL2—coronary artery disease	4.74e-05	0.000585	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL3—coronary artery disease	4.74e-05	0.000585	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—EDNRA—coronary artery disease	4.72e-05	0.000583	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADRB1—coronary artery disease	4.7e-05	0.00058	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—F2R—coronary artery disease	4.68e-05	0.000579	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—UTS2R—coronary artery disease	4.62e-05	0.000571	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FZD2—coronary artery disease	4.62e-05	0.000571	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—F2—coronary artery disease	4.62e-05	0.00057	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—EDNRB—coronary artery disease	4.54e-05	0.000561	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SFRP2—coronary artery disease	4.53e-05	0.00056	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOA4—coronary artery disease	4.45e-05	0.000549	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADORA3—coronary artery disease	4.45e-05	0.000549	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADORA1—coronary artery disease	4.45e-05	0.000549	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—BDKRB2—coronary artery disease	4.44e-05	0.000548	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL12—coronary artery disease	4.44e-05	0.000548	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PLCB1—coronary artery disease	4.34e-05	0.000536	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PGF—coronary artery disease	4.29e-05	0.000531	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PPBP—coronary artery disease	4.29e-05	0.000531	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—EDNRA—coronary artery disease	4.28e-05	0.000529	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	4.27e-05	0.000528	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADRB1—coronary artery disease	4.27e-05	0.000527	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR7—coronary artery disease	4.25e-05	0.000525	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ITGA2B—coronary artery disease	4.22e-05	0.000522	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DVL1—coronary artery disease	4.22e-05	0.000522	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—coronary artery disease	4.22e-05	0.000521	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—POMC—coronary artery disease	4.2e-05	0.00052	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCL2—coronary artery disease	4.11e-05	0.000508	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ALB—coronary artery disease	4.11e-05	0.000508	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—OPRD1—coronary artery disease	4.1e-05	0.000506	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL4—coronary artery disease	4.1e-05	0.000506	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GHR—coronary artery disease	4.1e-05	0.000506	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—PIK3CA—coronary artery disease	4.09e-05	0.000506	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—KNG1—coronary artery disease	4.04e-05	0.000499	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—BDKRB2—coronary artery disease	4.03e-05	0.000498	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL12—coronary artery disease	4.03e-05	0.000498	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AGTR1—coronary artery disease	4.01e-05	0.000496	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PLCB1—coronary artery disease	3.94e-05	0.000487	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TLE4—coronary artery disease	3.93e-05	0.000485	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MEF2A—coronary artery disease	3.93e-05	0.000485	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL10—coronary artery disease	3.92e-05	0.000484	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR7—coronary artery disease	3.86e-05	0.000477	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOA2—coronary artery disease	3.83e-05	0.000473	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADRB2—coronary artery disease	3.81e-05	0.00047	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AVPR1A—coronary artery disease	3.78e-05	0.000467	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PRKCE—coronary artery disease	3.76e-05	0.000464	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—KNG1—coronary artery disease	3.66e-05	0.000453	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	3.66e-05	0.000452	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—UTS2—coronary artery disease	3.65e-05	0.000451	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AGTR1—coronary artery disease	3.64e-05	0.00045	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NR4A1—coronary artery disease	3.57e-05	0.000442	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL10—coronary artery disease	3.56e-05	0.00044	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—P2RY12—coronary artery disease	3.54e-05	0.000437	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLCB3—coronary artery disease	3.54e-05	0.000437	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HDAC9—coronary artery disease	3.54e-05	0.000437	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CX3CR1—coronary artery disease	3.5e-05	0.000433	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CASR—coronary artery disease	3.5e-05	0.000433	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADRB2—coronary artery disease	3.46e-05	0.000427	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—BDKRB1—coronary artery disease	3.43e-05	0.000424	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GNA12—coronary artery disease	3.43e-05	0.000424	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—P4HB—coronary artery disease	3.43e-05	0.000424	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CX3CL1—coronary artery disease	3.43e-05	0.000424	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PRKCE—coronary artery disease	3.41e-05	0.000422	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—EDN1—coronary artery disease	3.4e-05	0.00042	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCL5—coronary artery disease	3.37e-05	0.000417	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PPP3R1—coronary artery disease	3.37e-05	0.000416	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADM—coronary artery disease	3.34e-05	0.000413	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CSF2—coronary artery disease	3.32e-05	0.000411	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CYBB—coronary artery disease	3.25e-05	0.000402	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PDE4B—coronary artery disease	3.25e-05	0.000402	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCL8—coronary artery disease	3.25e-05	0.000402	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—MMP3—coronary artery disease	3.25e-05	0.000401	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	3.24e-05	0.0004	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—EDN1—coronary artery disease	3.09e-05	0.000382	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL5—coronary artery disease	3.06e-05	0.000379	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PRKCD—coronary artery disease	3.04e-05	0.000376	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CSF2—coronary artery disease	3.02e-05	0.000373	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR3—coronary artery disease	2.98e-05	0.000368	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR2A—coronary artery disease	2.98e-05	0.000368	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—C3—coronary artery disease	2.97e-05	0.000367	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CRK—coronary artery disease	2.94e-05	0.000363	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ATP2A2—coronary artery disease	2.9e-05	0.000358	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SH2B3—coronary artery disease	2.9e-05	0.000358	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—VWF—coronary artery disease	2.9e-05	0.000358	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOC3—coronary artery disease	2.88e-05	0.000356	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LDLR—coronary artery disease	2.87e-05	0.000354	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AGT—coronary artery disease	2.82e-05	0.000349	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PPP2CA—coronary artery disease	2.81e-05	0.000347	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL3—coronary artery disease	2.8e-05	0.000346	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL2—coronary artery disease	2.8e-05	0.000346	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SDC1—coronary artery disease	2.77e-05	0.000342	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—F2R—coronary artery disease	2.77e-05	0.000342	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PRKCD—coronary artery disease	2.76e-05	0.000341	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGB—coronary artery disease	2.71e-05	0.000335	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR2A—coronary artery disease	2.7e-05	0.000334	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—C3—coronary artery disease	2.7e-05	0.000333	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EDNRB—coronary artery disease	2.68e-05	0.000331	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—THBS1—coronary artery disease	2.64e-05	0.000326	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PSMB5—coronary artery disease	2.61e-05	0.000323	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PSMA6—coronary artery disease	2.61e-05	0.000323	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—F2—coronary artery disease	2.61e-05	0.000322	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AGT—coronary artery disease	2.56e-05	0.000317	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EDNRA—coronary artery disease	2.53e-05	0.000313	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CYBA—coronary artery disease	2.52e-05	0.000311	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADRB1—coronary artery disease	2.52e-05	0.000311	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DUSP6—coronary artery disease	2.51e-05	0.00031	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLAT—coronary artery disease	2.47e-05	0.000305	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL12—coronary artery disease	2.38e-05	0.000294	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—BDKRB2—coronary artery disease	2.38e-05	0.000294	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—POMC—coronary artery disease	2.38e-05	0.000294	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—F2—coronary artery disease	2.37e-05	0.000293	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL6ST—coronary artery disease	2.36e-05	0.000292	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—JUNB—coronary artery disease	2.34e-05	0.000289	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLCB1—coronary artery disease	2.33e-05	0.000288	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR7—coronary artery disease	2.28e-05	0.000282	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ITGAV—coronary artery disease	2.17e-05	0.000268	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—KNG1—coronary artery disease	2.16e-05	0.000268	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—POMC—coronary artery disease	2.16e-05	0.000267	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CREB1—coronary artery disease	2.16e-05	0.000267	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AGTR1—coronary artery disease	2.15e-05	0.000266	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL2—coronary artery disease	2.11e-05	0.000261	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL6R—coronary artery disease	2.1e-05	0.00026	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL10—coronary artery disease	2.1e-05	0.00026	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLG—coronary artery disease	2.1e-05	0.000259	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADRB2—coronary artery disease	2.04e-05	0.000252	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRKCE—coronary artery disease	2.02e-05	0.000249	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—JAK2—coronary artery disease	2.01e-05	0.000249	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SOCS1—coronary artery disease	2.01e-05	0.000248	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—S100B—coronary artery disease	2.01e-05	0.000248	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SOCS3—coronary artery disease	1.99e-05	0.000245	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—KITLG—coronary artery disease	1.96e-05	0.000243	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TGFBR2—coronary artery disease	1.96e-05	0.000243	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—STAT5A—coronary artery disease	1.92e-05	0.000237	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MMP3—coronary artery disease	1.92e-05	0.000237	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOB—coronary artery disease	1.85e-05	0.000229	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	1.84e-05	0.000227	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	1.83e-05	0.000226	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EDN1—coronary artery disease	1.82e-05	0.000225	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL5—coronary artery disease	1.81e-05	0.000224	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CSF2—coronary artery disease	1.78e-05	0.00022	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGF1—coronary artery disease	1.78e-05	0.00022	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LPL—coronary artery disease	1.77e-05	0.000219	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	1.75e-05	0.000217	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	1.75e-05	0.000217	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	1.71e-05	0.000211	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	1.67e-05	0.000206	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	1.66e-05	0.000205	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	1.63e-05	0.000202	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	1.6e-05	0.000197	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—C3—coronary artery disease	1.59e-05	0.000197	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	1.52e-05	0.000188	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AGT—coronary artery disease	1.51e-05	0.000187	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LEP—coronary artery disease	1.48e-05	0.000183	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOE—coronary artery disease	1.48e-05	0.000183	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOA1—coronary artery disease	1.47e-05	0.000181	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—KDR—coronary artery disease	1.45e-05	0.00018	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	1.44e-05	0.000178	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ESR1—coronary artery disease	1.42e-05	0.000175	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FN1—coronary artery disease	1.4e-05	0.000173	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—F2—coronary artery disease	1.4e-05	0.000173	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	1.39e-05	0.000172	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	1.38e-05	0.000171	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—KIT—coronary artery disease	1.34e-05	0.000165	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	1.28e-05	0.000159	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—POMC—coronary artery disease	1.27e-05	0.000158	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CREB1—coronary artery disease	1.27e-05	0.000158	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL2—coronary artery disease	1.25e-05	0.000154	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL6R—coronary artery disease	1.24e-05	0.000154	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IGF1—coronary artery disease	1.23e-05	0.000152	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	1.22e-05	0.000151	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.17e-05	0.000144	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	1.16e-05	0.000144	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGF2—coronary artery disease	1.13e-05	0.000139	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NOS3—coronary artery disease	1.11e-05	0.000137	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—JAK2—coronary artery disease	1.08e-05	0.000134	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	1.06e-05	0.000131	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	9.86e-06	0.000122	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	9.52e-06	0.000118	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CASP3—coronary artery disease	9.44e-06	0.000117	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL6—coronary artery disease	9.38e-06	0.000116	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCND1—coronary artery disease	9.19e-06	0.000114	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MMP9—coronary artery disease	8.92e-06	0.00011	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	8.65e-06	0.000107	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	8.01e-06	9.9e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	7.35e-06	9.08e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	7.21e-06	8.91e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	6.25e-06	7.73e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL6—coronary artery disease	5.54e-06	6.84e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AKT1—coronary artery disease	5.11e-06	6.31e-05	CbGpPWpGaD
